CX3CL1 and Alzheimer disease: In a cohort encompassing AD patients, aMCI patients, and CN subjects, urinary CX3CL1 levels showed no correlation with MMSE scores among all participants (Figure 3A) and in females (Supplementary Figure S2A females).